Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 29, 2017
Stable Isotope Labeling Reveals Novel Insights Into Ubiquitin-Mediated Protein Aggregation With Age, Calorie Restriction, and Rapamycin TreatmentNathan B Basisty, Yuxin Liu, Jason Reynolds, et al.Cancer Research|April 15, 2022
Colorectal Cancer Is Associated with the Presence of Cancer Driver Mutations in Normal ColonJulia Matas, Brendan Kohrn, Jeanne Fredrickson, et al.Geroscience|April 13, 2022
Age-related disruption of the proteome and acetylome in mouse hearts is associated with loss of function and attenuated by elamipretide (SS-31) and nicotinamide mononucleotide (NMN) treatmentJeremy A Whitson, Richard Johnson, Lu Wang, et al.Aging Cell|April 11, 2016
Mitochondrial-targeted catalase is good for the old mouse proteome, but not for the young: 'reverse' antagonistic pleiotropy?Nathan Basisty, Dao-Fu Dai, Arni Gagnidze, et al.Gynecologic Oncology|April 18, 2025
TP53 somatic evolution in the normal endometrium of Black and White individualsEric Rios-Doria, Elizabeth U Parker, Brendan F Kohrn, et al.Oncogene|June 25, 2024
TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutationsTalayeh S Ghezelayagh, Brendan F Kohrn, Jeanne Fredrickson, et al.Nucleic Acids Research|October 6, 2021
A replication-linked mutational gradient drives somatic mutation accumulation and influences germline polymorphisms and genome composition in mitochondrial DNAMonica Sanchez-Contreras, Mariya T Sweetwyne, Brendan F Kohrn, et al.Aging Cell|December 12, 2019
Rapamycin persistently improves cardiac function in aged, male and female mice, even following cessation of treatmentEllen Quarles, Nathan Basisty, Ying Ann Chiao, et al.Gynecologic Oncology|December 17, 2019
Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinomaJeffrey D Krimmel-Morrison, Talayeh S Ghezelayagh, Shenyi Lian, et al.Haematologica|September 14, 2023
Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapiesDavid W Woolston, Nathan D Lee, Mazyar Shadman, et al.Pageof 2